Add to MyYahoo RSS

bladder cancer News

News on bladder cancer continually updated from thousands of sources around the net.

13 hrs ago | Scoop

Kaiser Permanente signs up for Cxbladder

Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.


Related Topix: Kaiser Permanente, Medicine, Hospital Administration, Healthcare Industry, Oceania, New Zealand, World News, Hershey, PA, Urology

17 hrs ago | WGN-TV Chicago

Cardinal George cancels trip to Rome so he can receive cancer treatment

Cardinal Francis George will miss a planned trip to Rome in October to instead receive treatment for cancer, the Archdiocese of Chicago said Tuesday.


Related Topix: Medicine, Cancer, Health

Yesterday | PhysOrg Weblog

New tool to probe cancer's molecular make-up

Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.


Related Topix: Medicine, Cancer, Health, Biology, Science, Oncology, Lung Cancer

Mon Aug 25, 2014

DFW Catholic

Cardinal George participating in clinical trial of anti-cancer drug

Chicago, Ill., Aug 25, 2014 / 10:46 am .- Cardinal Francis George of Chicago is continuing cancer treatment and has agreed to take part in a clinical trial of a new anti-cancer drug, his archdiocese has announced.


Related Topix: Medicine, Cancer, Health, University of Chicago

Applied Clinical Trials

Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a ...

This new PD-L1 clone was developed for Roche/Genentech's anti-PD-L1 immunotherapy development program.


Related Topix: Biotech, Medicine, Roche Group, Healthcare Industry, Ventana Medical Systems, Medical Equipment, Health, Lung Cancer

Fri Aug 22, 2014

Chicago Tribune

Cardinal George testing new cancer drug

Cardinal Francis George, facing his third bout with cancer, is participating in a clinical trial of a new drug being conducted at the University of Chicago, the archdiocese announced Friday.


Related Topix: University of Chicago, Health

Thu Aug 21, 2014


Building Presence in World's Largest Biomedical Market

At its annual shareholders' meeting held yesterday in Dunedin, New Zealand, cancer diagnostic developer, Pacific Edge, celebrated the commercial launch of its flagship bladder cancer diagnostic product, Cxbladder, into the US and provided shareholders with an update on its growth plans.


Related Topix: New Zealand, World News, Health, Marketing, Medicine, Urology, Medicaid

PhysOrg Weblog

Surgery associated with better survival for patients with advanced laryngeal cancer

Approximately 11,000 to 13,000 cases of laryngeal cancer are diagnosed each year and squamous cell carcinoma accounts for the vast majority of these tumors.


Related Topix: Medicine, Cancer, Health, Mount Sinai, NY, Lung Cancer, Skin Cancer, Pancreatic Cancer

Arutz Sheva Israel News

Technology & HealthWoman's Cancer Drives Daughter to Research Breakthrough

Dr. Svetlana Bunimovich, lecturer in the Department of Computer Science and Mathematics at the University of Ariel, will present research done using mathematical models, to improve the treatment of bladder cancer, at a conference to be held at Ariel University next week .


Related Topix: Cancer, Medicine, Health, Mathematics, Science

Wed Aug 20, 2014


Validation of RiskCheck Bladder Cancera OEA , version 5.0 for...

The aim of the study was to assess the strength of the online tool RiskCheck Bladder CancerA©, version 5.0 for early detection of bladder cancer .


Related Topix: Health, Mathematics, Science

Hispanic Business

Largest cancer genomic study proposes 'disruptive' new system to reclassify tumors

TCGA scientists analyzed the DNA, RNA and protein from 12 different tumor types using six different TCGA "platform technologies" to see how the different tumor types compare to each other.


Related Topix: Cancer, Health, Breast Cancer

Tue Aug 19, 2014

The Independent

Revealed: The most devastating failures by public services

Paul Gallagher is a reporter for the Independent and Independent on Sunday having joined the group in 2012.


Related Topix: Health


Bioniche Life Sciences Inc. Announces Q1/2015 Timeline For The Filing ...

This projected timeline integrates the conclusions of a regulatory gap analysis prepared by its consultants with the planning and scheduling of a pre-BLA meeting between Bioniche and the FDA prior to the BLA filing.


Related Topix: Food and Drug Administration, Health

Customer Interaction Solutions

Altor BioScience Awarded SBIR Phase II Grant by NCI for Clinical...

Altor BioScience Corporation , a leading developer of cancer immunotherapies, announced today that it has been awarded a Small Business Innovation Research Phase II grant by the National Cancer Institute for the clinical development of ALT-803, a proprietary interleukin-15 superagonist protein complex, against non-muscle invasive bladder cancer .


Related Topix: Cancer, Medicine, Health

Sat Aug 16, 2014

Market Report, "Marina Biotech, Inc. (MRNA) - Pharmaceuticals &...

It develops and commercializes therapeutic products based on RNS interference and mRNA translational blocking.


Related Topix: Biotech, MDRNA, Science / Technology, Medicine, Nursing, Health, Bothell, WA

Thu Aug 14, 2014


Father of newborn son struggling with aggressive cancer battle

A Northampton County dad needs your help. Just weeks after his son was born, he found out he has a rare and aggressive cancer.


Related Topix: Health

Wed Aug 13, 2014

BioMed Central

Could Hyaluronic acid (HA) reduce Bacillus Calmette-Guerin (BCG)...

Bacillus Calmette-Guerin is considered the most effective treatment to reduce recurrence and progression of non-muscle invasive bladder cancer but can induce local side effects leading to treatment discontinuation or interruption.


Related Topix: Health

Business Journal

Tengion says regenerative kidney treatment trial on track

Tengion , the Winston-Salem biotech company working to commercialize some of the technologies developed by Dr. Anthony Atala and the Wake Forest Institute for Regenerative Medicine , said the Phase 1 clinical trial of its Neo-Kidney Augment is on track so far.


Related Topix: Tengion, Health


Clinical trial tests COXEN model to predict best treatment for bladder cancer

Imagine being able to match a cancer's genes to the best treatment. That's the promise of COXEN - a computer program that looks at a panel of cancer genes in a patient's tumor to predict whether it will respond to chemotherapy.


Related Topix: Medicine, Cancer, Health, National Cancer Institute, Charitable Organizations, Oncology, Urology, Pharmacology

Tue Aug 12, 2014

New Albany Gazette

Bladder surgery and a priest

Jenny was prepared for the worst when she was wheeled into her room after bladder surgery at Baptist Memorial Hospital in Oxford and was met by a priest.


Related Topix: Baptist Memorial Hospital, Hospital Administration, Healthcare Industry, New Albany, MS, Health